St. Jude Children's Research Hospital
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.stjude.org/
Evaluation of the Safety of a Polyvalent Virus in Healthy Adults
Phase 1
Completed
- Conditions
- HIV InfectionHuman Immunodeficiency Virus
- Interventions
- Biological: PolyEnv1 vaccine
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2011-09-29
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT00187044
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2011-09-20
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 14
- Registration Number
- NCT00186953
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Phase 3
Terminated
- Conditions
- Acute Lymphoblastic Leukemia
- Interventions
- Drug: Prednisone, Dexamethasone, Vincristine, Daunorubicin, PEG-L-asparaginase
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2011-03-30
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 53
- Registration Number
- NCT00187005
- Locations
- 🇺🇸
St.Jude Children's Research Hospital, Memphis, Tennessee, United States
Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL
Phase 2
Completed
- Conditions
- Non-Hodgkin LymphomaAcute Lymphoblastic Leukemia, Mature B-Cell
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2008-06-04
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 68
- Registration Number
- NCT00187161
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies
Phase 3
Completed
- Conditions
- Leukemia, Acute Lymphocytic (ALL)Leukemia, Myeloid, Acute(AML)Leukemia, Myeloid, Chronic(CML)Juvenile Myelomonocytic Leukemia(JMML)Hemoglobinuria, Paroxysmal Nocturnal (PNH)Lymphoma, Non-Hodgkin (NHL)Myelodysplastic Syndrome (MDS)
- Interventions
- Device: Miltenyi Biotec CliniMACSProcedure: Stem Cell Transplantation
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2009-01-29
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 57
- Registration Number
- NCT00186823
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease
Phase 2
Completed
- Conditions
- Sickle Cell Disease
- Interventions
- Drug: Busulfan, Cyclophosphamide, Horse ATGProcedure: Allogeneic stem cell transplant
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2009-05-29
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT00186810
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Therapy for Children With Advanced Stage High Risk Neuroblastoma
Phase 2
Completed
- Conditions
- Neuroblastoma
- Interventions
- Drug: Topotecan, Cyclophosphamide, Cisplatin, Doxorubicin, Etoposide, Ifosfamide, CarboplatinProcedure: Peripheral Blood Stem Cell Transplant
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2009-05-20
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT00186849
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia
Not Applicable
Completed
- Conditions
- Aplastic Anemia
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2010-04-09
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 28
- Registration Number
- NCT00186797
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
A Study of Children With Refractory or Relapsed ALL
Phase 3
Completed
- Conditions
- Acute Lymphoblastic Leukemia
- Interventions
- Drug: E. coli Asparaginase, PEG-L-asparaginaseProcedure: chemotherapy, intrathecal chemotherapy, steroid therapy
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2008-06-04
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00187083
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2008-06-03
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT00186862
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath